Anbio Biotechnology
$3.40
12
+$0.04+1.19% 10:53 Today
Statistics
Day High
3.47
Day Low
3.33
52W High
44.73
52W Low
3.09
Volume
2,118
Avg. Volume
-
Mkt Cap
147.47M
P/E Ratio
66.47
Dividend Yield
-
Dividend
-
Financials
74.05%Profit Margin
Profitable8.65MRevenue
6.4MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NNNN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Show More
CEO
Michael Lau
Employees
27
Country
Cayman Islands
ISIN
KYG0367B1059
WKN
000A40J71
Listings
0 Comments
Share your thoughts
FAQs
What is Anbio Biotechnology stock price today?▼
The current price of NNNN is $3.40 USD — it has increased by +1.19% in the past 24 hours. Watch Anbio Biotechnology stock price performance more closely on the chart.
What is Anbio Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Anbio Biotechnology stocks are traded under the ticker NNNN.
Is Anbio Biotechnology stock price growing?▼
NNNN stock has fallen by -9.19% compared to the previous week, the month change is a -39.46% fall, over the last year Anbio Biotechnology has showed a -80.06% decrease.
What is Anbio Biotechnology market cap?▼
Today Anbio Biotechnology has the market capitalization of 147.47M
What is Anbio Biotechnology revenue for the last year?▼
Anbio Biotechnology revenue for the last year amounts to 8.65M USD.
What is Anbio Biotechnology net income for the last year?▼
NNNN net income for the last year is 6.4M USD.
How many employees does Anbio Biotechnology have?▼
As of November 2, 2026, the company has 27 employees.
In which sector is Anbio Biotechnology located?▼
Anbio Biotechnology operates in the Health & Wellness sector.
When did Anbio Biotechnology complete a stock split?▼
Anbio Biotechnology has not had any recent stock splits.
Where is Anbio Biotechnology headquartered?▼
Anbio Biotechnology is headquartered in Frankfurt am Main, Cayman Islands.